Michael L. Booker

940 total citations
19 papers, 520 citations indexed

About

Michael L. Booker is a scholar working on Molecular Biology, Oncology and Surgery. According to data from OpenAlex, Michael L. Booker has authored 19 papers receiving a total of 520 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 6 papers in Oncology and 5 papers in Surgery. Recurrent topics in Michael L. Booker's work include Drug Transport and Resistance Mechanisms (4 papers), Biochemical and Molecular Research (3 papers) and Pediatric Hepatobiliary Diseases and Treatments (3 papers). Michael L. Booker is often cited by papers focused on Drug Transport and Resistance Mechanisms (4 papers), Biochemical and Molecular Research (3 papers) and Pediatric Hepatobiliary Diseases and Treatments (3 papers). Michael L. Booker collaborates with scholars based in United States, Spain and Switzerland. Michael L. Booker's co-authors include Thayer E. Scott, Wayne W. LaMorte, Bradley S. Turner, J. T. LaMont, Dyann F. Wirth, Martin Kramer, D P O'Leary, Leila S. Ross, Yibin Xiang and John L. Kane and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Gastroenterology.

In The Last Decade

Michael L. Booker

19 papers receiving 503 citations

Peers

Michael L. Booker
Donna L. Perry United States
Herman Polet United States
Yuqi Zhou China
Ae‐Ran Choi South Korea
Neeraj Kapoor United States
I A Finnie United Kingdom
Siddeswar Gubba United States
Michael L. Booker
Citations per year, relative to Michael L. Booker Michael L. Booker (= 1×) peers Jesús Oria‐Hernández

Countries citing papers authored by Michael L. Booker

Since Specialization
Citations

This map shows the geographic impact of Michael L. Booker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael L. Booker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael L. Booker more than expected).

Fields of papers citing papers by Michael L. Booker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael L. Booker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael L. Booker. The network helps show where Michael L. Booker may publish in the future.

Co-authorship network of co-authors of Michael L. Booker

This figure shows the co-authorship network connecting the top 25 collaborators of Michael L. Booker. A scholar is included among the top collaborators of Michael L. Booker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael L. Booker. Michael L. Booker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Rouaud, Cédric, et al.. (2019). A Comparison of Model Order Reduction Techniques for Real-Time Battery Thermal Modelling. SAE technical papers on CD-ROM/SAE technical paper series. 1. 4 indexed citations
2.
Cosner, Casey C., Martin Kramer, Michael L. Booker, et al.. (2017). Identification ofTrypanosoma bruceiAdoMetDC Inhibitors Using a High-Throughput Mass Spectrometry-Based Assay. ACS Infectious Diseases. 3(7). 512–526. 13 indexed citations
3.
Crowther, Gregory J., Michael L. Booker, Min He, et al.. (2014). Cofactor-Independent Phosphoglycerate Mutase from Nematodes Has Limited Druggability, as Revealed by Two High-Throughput Screens. PLoS neglected tropical diseases. 8(1). e2628–e2628. 20 indexed citations
4.
Lukens, Amanda K., Leila S. Ross, Richard W. Heidebrecht, et al.. (2013). Harnessing evolutionary fitness in Plasmodium falciparum for drug discovery and suppressing resistance. Proceedings of the National Academy of Sciences. 111(2). 799–804. 44 indexed citations
5.
Skerlj, Renato T., Cecilia M. Bastos, Michael L. Booker, et al.. (2011). Optimization of Potent Inhibitors of P. falciparum Dihydroorotate Dehydrogenase for the Treatment of Malaria. ACS Medicinal Chemistry Letters. 2(9). 708–713. 34 indexed citations
6.
Xiang, Yibin, Bradford Hirth, John L. Kane, et al.. (2010). Discovery of novel sphingosine kinase-1 inhibitors. Part 2. Bioorganic & Medicinal Chemistry Letters. 20(15). 4550–4554. 39 indexed citations
7.
Byrne, Annette T., Paul Mason, Michael R. Dufault, et al.. (2009). Knockdown of human deubiquitinase PSMD14 induces cell cycle arrest and senescence. Experimental Cell Research. 316(2). 258–271. 54 indexed citations
8.
Xiang, Yibin, et al.. (2009). Discovery of novel sphingosine kinase 1 inhibitors. Bioorganic & Medicinal Chemistry Letters. 19(21). 6119–6121. 41 indexed citations
9.
Patel, Vishal, Michael L. Booker, Martin Kramer, et al.. (2008). Identification and Characterization of Small Molecule Inhibitors of Plasmodium falciparum Dihydroorotate Dehydrogenase. Journal of Biological Chemistry. 283(50). 35078–35085. 59 indexed citations
10.
Booker, Michael L.. (2001). Lp-PLA2 inhibitors (GlaxoSmithKline).. PubMed. 4(10). 1173–7. 3 indexed citations
11.
LaMorte, Wayne W., et al.. (1998). Determinants of the selection of phosphatidylcholine molecular species for secretion into bile in the rat. Hepatology. 28(3). 631–637. 14 indexed citations
12.
Booker, Michael L., et al.. (1997). Effects of dietary cholesterol and triglycerides on lipid concentrations in liver, plasma, and bile. Lipids. 32(2). 163–172. 6 indexed citations
13.
Booker, Michael L. & Wayne W. LaMorte. (1994). Biliary phospholipases in the prairie dog model for cholesterol cholelithiasis. Hepatology. 19(3). 743–749. 4 indexed citations
14.
LaMorte, Wayne W., D P O'Leary, Michael L. Booker, & Thayer E. Scott. (1993). Increased dietary fat content accelerates cholesterol gallstone formation in the cholesterol-fed prairie dog. Hepatology. 18(6). 1498–1503. 16 indexed citations
15.
O'Leary, D P, Wayne W. LaMorte, Thayer E. Scott, Michael L. Booker, & John C. Stevenson. (1991). Inhibition of prostaglandin synthesis fails to prevent gallbladder mucin hypersecretion in the cholesterol-fed prairie dog. Gastroenterology. 101(3). 812–820. 29 indexed citations
16.
Booker, Michael L., et al.. (1990). Effects of dietary fish oil on biliary phospholipids and prostaglandin synthesis in the cholesterol‐fed pairie dog. Lipids. 25(1). 27–32. 32 indexed citations
17.
Booker, Michael L., et al.. (1989). Effect of dietary cholesterol on phosphatidylcholines and phosphatidylethanolamines in bile and gallbladder mucosa in the prairie dog. Gastroenterology. 97(5). 1261–1267. 31 indexed citations
18.
LaMorte, Wayne W., et al.. (1986). Gallbladder prostaglandins and lysophospholipids as mediators of mucin secretion during cholelithiasis. American Journal of Physiology-Gastrointestinal and Liver Physiology. 251(5). G701–G709. 65 indexed citations
19.
Booker, Michael L. & Wayne W. LaMorte. (1983). Prostaglandin release from in vitro guinea-pig gallbladder. Prostaglandins. 25(2). 143–153. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026